HIMS Hims & Hers Health Inc
- Stocks
- Consumer Defensive
- NYSE: HIMS
Price (delayed)
$46.23
Market cap
$10.45B
P/E Ratio
53.14
Dividend/share
N/A
EPS
$0.87
Enterprise value
$10.37B
Hims & Hers is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual
Highlights
Hims & Hers Health's quick ratio has surged by 100% YoY
Hims & Hers Health's revenue has soared by 89% YoY and by 13% from the previous quarter
The stock's P/E is 22% more than its last 4 quarters average of 44.5
Hims & Hers Health's gross margin has decreased by 7% YoY
Key stats
What are the main financial stats of HIMS
Market
Valuations
Earnings
Shares outstanding
226.02M
Market cap
$10.45B
Enterprise value
$10.37B
Price to earnings (P/E)
53.14
Price to book (P/B)
18.39
Price to sales (P/S)
5.15
EV/EBIT
74.47
EV/EBITDA
59.47
EV/Sales
5.15
Revenue
$2.01B
Gross profit
$1.53B
Operating income
$125.59M
Net income
$193.6M
EBIT
$139.23M
EBITDA
$174.34M
Free cash flow
$119.51M
Per share
Balance sheet
Liquidity
EPS
$0.87
EPS diluted
$0.79
Free cash flow per share
$0.53
Book value per share
$2.51
Revenue per share
$8.97
TBVPS
$7.66
Total assets
$1.88B
Total liabilities
$1.31B
Debt
$1.04B
Equity
$562.7M
Working capital
$1.08B
Debt to equity
1.86
Current ratio
4.98
Quick ratio
4.21
Net debt/EBITDA
-0.46
Margins
Efficiency
Dividend
EBITDA margin
8.7%
Gross margin
76.2%
Net margin
9.6%
Operating margin
6.2%
Return on assets
19%
Return on equity
38.2%
Return on invested capital
29.9%
Return on capital employed
8.7%
Return on sales
6.9%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
HIMS stock price
How has the Hims & Hers Health stock price performed over time
Intraday
-1.91%
1 week
-10.99%
1 month
-8.38%
1 year
194.27%
YTD
91.19%
QTD
-7.26%
Financial performance
How have Hims & Hers Health's revenue and profit performed over time
Revenue
$2.01B
Gross profit
$1.53B
Operating income
$125.59M
Net income
$193.6M
Gross margin
76.2%
Net margin
9.6%
Hims & Hers Health's revenue has soared by 89% YoY and by 13% from the previous quarter
HIMS's gross profit has soared by 75% YoY and by 12% from the previous quarter
HIMS's net income is up by 18% since the previous quarter
The operating income is up by 14% QoQ
Price vs fundamentals
How does HIMS's price correlate with its fundamentals
Growth
What is Hims & Hers Health's growth rate over time
Valuation
What is Hims & Hers Health stock price valuation
P/E
53.14
P/B
18.39
P/S
5.15
EV/EBIT
74.47
EV/EBITDA
59.47
EV/Sales
5.15
The stock's P/E is 22% more than its last 4 quarters average of 44.5
Hims & Hers Health's EPS has increased by 18% QoQ
The price to book (P/B) is 150% higher than the 5-year quarterly average of 7.5 and 44% higher than the last 4 quarters average of 13.0
The equity has surged by 55% year-on-year and by 2.4% since the previous quarter
Hims & Hers Health's revenue has soared by 89% YoY and by 13% from the previous quarter
The P/S is 31% higher than the last 4 quarters average of 4.0 and 25% higher than the 5-year quarterly average of 4.2
Efficiency
How efficient is Hims & Hers Health business performance
The ROIC has soared by 92% year-on-year but it has dropped by 61% since the previous quarter
The company's return on assets fell by 22% QoQ
The ROE has grown by 6% from the previous quarter
Hims & Hers Health's return on sales has increased by 3% QoQ
Dividends
What is HIMS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for HIMS.
Financial health
How did Hims & Hers Health financials performed over time
Hims & Hers Health's total assets is 43% higher than its total liabilities
Hims & Hers Health's total assets has surged by 111% QoQ
Hims & Hers Health's quick ratio has surged by 100% YoY
The debt is 86% more than the equity
The equity has surged by 55% year-on-year and by 2.4% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.